Skip to main content
. 2016 Dec 15;2016(12):CD011918. doi: 10.1002/14651858.CD011918.pub2

Summary of findings for the main comparison. Protease‐modulating matrix dressing regimen compared to any other dressing regimen for healing venous leg ulcers.

Protease‐modulating matrix dressing compared to advanced dressings/no dressing for venous leg ulcers
Patient or population: people with venous leg ulcers
 Intervention: PMM dressing regimen
 Comparison: other dressing regimen; different comparators across studies
Outcomes Absolute effect* (95% CI) Relative effect
 (95% CI) № of participants
 (studies) Certainty of the evidence
 (GRADE)
Risk with other dressing regimen Risk with PMM dressing regimen
TIme to complete healing Estimated median time to complete healing: 3 months Estimated median time to complete healing: 4.5 months HR 1.21
 (0.74 to 1.97) 100
 (1 RCTǂ)
66 events
⊕⊕⊝⊝
 LOW 1
Difference in estimated median time to complete healing: approximately 1.5 months shorter
Proportion of participants healed ‐ short term (4‐8 weeks) 287 per 1000 210 per 1000 RR 0.73
 (0.34 to 1.58) 207
 (2 RCTs)
21 events
⊕⊝⊝⊝
 VERY LOW 2
Difference: 77 fewer wounds healed per 1000
(95% CI 167 more to 190 fewer)
Proportion of participants healed ‐ medium term (12 weeks) 400 per 1000 512 per 1000 RR 1.28
 (0.95 to 1.71) 192
 (4 RCTs)
89 events
⊕⊕⊝⊝
 LOW 3
Difference: 112 more wounds healed per 1000
(95% CI 20 fewer to 284 more)
Proportion of participants healed ‐ long term (over 24 weeks) 640 per 1000 678 per 1000
 (512 to 902) RR 1.06
 (0.80 to 1.41) 100
 (1 RCTǂ)
66 events
⊕⊕⊝⊝
 LOW 4
Difference: 38 more wounds healed per 1000
(95% CI 128 fewer to 262 more)
Proportion of participants with 1 or more adverse events at 2‐12 weeks 172 per 1000 178 per 1000 RR 1.03
 (0.75 to 1.42) 363
 (5 RCTs)
99 events
⊕⊕⊝⊝
 LOW 5
Difference: 6 more adverse events per 1000
(95% CI 43 fewer to 72 more)
*The risk without the intervention is based on the median control group risk across studies. The corresponding risk with the intervention (and the 95% confidence interval for the difference) is based on the overall relative effect (and its 95% confidence interval).
ǂ Same study (Petkov 1997)
 
 CI: Confidence interval; RR: Risk ratio; OR: Odds ratio
GRADE Working Group grades of evidence
High: It is very likely that the effect will be close to what was found in the research.
Moderate: It is likely that the effect will be close to what was found in the research, but there is a possibility that it will be substantially different.
Low: It is likely that the effect will be substantially different from what was found in the research, but the research provides an indication of what might be expected.
Very low: The anticipated effect is very uncertain and the research does not provide a reliable indication of what might be expected

1 Imprecision (downgraded twice): 66 events, wide CI; assumptions in calculation of HR ‐ no censoring (not downgraded); data extracted from graph (not downgraded)

2 Risk of bias (downgraded once): majority of information at high risk of bias. Imprecision (downgraded twice): 21 events and wide CI

3 Risk of bias (downgraded once): majority of information at high risk of bias. Imprecision (downgraded once): 89 events, CI consistent with no effect and benefit

4 Imprecision (downgraded twice): 66 events, wide CI around absolute effect

5 Risk of bias (not downgraded): majority of information at low risk of bias. Imprecision (downgraded twice): 99 events, CI wide around relative effect